Ripple keeps stacking licenses, bank deals, and regulatory wins, yet the XRP price barely moves. Here is what it would actually take to carry XRP from $1.10 into territory no cryptocurrency except Bitcoin has…
Nebius just unveiled an asset-light pivot designed to outmaneuver CoreWeave and the miner-to-AI crowd, yet the stock is cratering anyway. Here is what the selloff reveals about which neocloud models can actually survive the…
Live Updates Stay On This Site to Receive Live $ISRG Q2 Earnings Updates3:26pm ETThis live blog is being updated by Thomas Richmond, a 24/7 Wall St. contributor. You’ll get expert analysis of Intuitive Surgical’s…
Live Updates Stay On This Site to Receive Live Netflix Q2 Earnings Updates3:24pm ETThis live blog is being updated by Thomas Richmond, a 24/7 Wall St. contributor. You’ll get expert analysis of Netflix’s Q2…
More than 80% of the AI infrastructure buildout projected through 2028 has yet to happen, and three ETFs are quietly positioning investors to capture what comes next.
Every time Amazon dips, one investor keeps adding shares while Wall Street fixates on a capex blowout that obscures something far more important hiding in the filing.
IREN stock has shed 41% in a single month alongside every major miner-turned-AI-infrastructure name, but a $3.4 billion NVIDIA contract and zero idle GPUs tell a very different story than the price action suggests.
Bank of America just flagged a hidden revenue engine inside Nvidia that the market is still ignoring, and the numbers suggest Wall Street has been pricing the wrong business this entire time.
BNY Mellon and State Street both posted record quarters, but their strategies are moving in opposite directions and only one of them faces a fee war that could quietly erode everything investors are celebrating…
Eli Lilly just wrote a $2.8 billion check on a psychedelic nasal spray that won't have pivotal trial data until 2029, and the reasoning behind that bet reveals where Big Pharma thinks depression treatment…
Arm shares have shed nearly a third of their value since mid-June, and investors now face a fork in the road between a bargain and a value trap. Our proprietary model points firmly in…
Coca-Cola shares are up 22% this year and the stock keeps setting new highs, yet Wall Street's consensus target barely budges. A closer look at the Q1 numbers and two-year earnings trajectory reveals why…
Bill Ackman charges a steep 2% fee for access to his concentrated portfolio, but two low-cost Vanguard ETFs quietly hold many of his highest-conviction bets for a fraction of the price.
AMD's jaw-dropping rally has momentum traders piling in, but one overlooked ETF is quietly outmaneuvering the chaos while paying investors to wait. The numbers behind the comparison will change how you think about positioning…
Oracle has shed a third of its value in weeks, and the obvious alternatives are moving in opposite directions. Before rotating into Cloudflare, CoreWeave, or Snowflake, investors need to understand which of these names…
